Increasing Brain Gamma Activity Improves Episodic Memory and Restores Cholinergic Dysfunction in Alzheimer's Disease.
Journal
Annals of neurology
ISSN: 1531-8249
Titre abrégé: Ann Neurol
Pays: United States
ID NLM: 7707449
Informations de publication
Date de publication:
08 2022
08 2022
Historique:
revised:
13
05
2022
received:
18
10
2021
accepted:
16
05
2022
pubmed:
25
5
2022
medline:
28
7
2022
entrez:
24
5
2022
Statut:
ppublish
Résumé
This study aimed to assess whether non-invasive brain stimulation with transcranial alternating current stimulation at gamma-frequency (γ-tACS) applied over the precuneus can improve episodic memory and modulate cholinergic transmission by modulating cerebral rhythms in early Alzheimer's disease (AD). In this randomized, double-blind, sham controlled, crossover study, 60 AD patients underwent a clinical and neurophysiological evaluation including assessment of episodic memory and cholinergic transmission pre and post 60 minutes treatment with γ-tACS targeting the precuneus or sham tACS. In a subset of 10 patients, EEG analysis and individualized modelling of electric field distribution were carried out. Predictors to γ-tACS efficacy were evaluated. We observed a significant improvement in the Rey Auditory Verbal Learning (RAVL) test immediate recall (p < 0.001) and delayed recall scores (p < 0.001) after γ-tACS but not after sham tACS. Face-name associations scores improved with γ-tACS (p < 0.001) but not after sham tACS. Short latency afferent inhibition, an indirect measure of cholinergic transmission, increased only after γ-tACS (p < 0.001). ApoE genotype and baseline cognitive impairment were the best predictors of response to γ-tACS. Clinical improvement correlated with the increase in gamma frequencies in posterior regions and with the amount of predicted electric field distribution in the precuneus. Precuneus γ-tACS, able to increase γ-power activity on the posterior brain regions, showed a significant improvement of episodic memory performances, along with restoration of intracortical excitability measures of cholinergic transmission. Response to γ-tACS was dependent on genetic factors and disease stage. ANN NEUROL 2022;92:322-334.
Identifiants
pubmed: 35607946
doi: 10.1002/ana.26411
pmc: PMC9546168
doi:
Substances chimiques
Cholinergic Agents
0
Banques de données
ClinicalTrials.gov
['NCT04842955']
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
322-334Informations de copyright
© 2022 The Authors. Annals of Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.
Références
Sci Adv. 2020 Sep 2;6(36):
pubmed: 32917605
Nature. 2016 Aug 31;537(7618):50-6
pubmed: 27582220
Neuropharmacology. 2017 Feb;113(Pt A):45-59
pubmed: 27647493
Neuroimage Clin. 2016 Jan 20;11:106-115
pubmed: 26937378
Lancet Neurol. 2011 Mar;10(3):241-52
pubmed: 21349439
Front Hum Neurosci. 2018 May 25;12:211
pubmed: 29887799
Front Hum Neurosci. 2016 May 25;10:245
pubmed: 27252642
Alzheimers Dement (N Y). 2020 Apr 07;6(1):e12005
pubmed: 32313830
J Neurosci. 2013 Jul 3;33(27):11262-75
pubmed: 23825429
Alzheimers Dement. 2018 Apr;14(4):535-562
pubmed: 29653606
Neuroimage. 2018 Apr 1;169:302-311
pubmed: 29277405
Ann Neurol. 2016 Sep;80(3):472-6
pubmed: 27438089
Clin Neurophysiol. 2013 May;124(5):837-50
pubmed: 23098644
Ann Neurol. 2020 Mar;87(3):394-404
pubmed: 31925823
Nature. 2016 Dec 7;540(7632):230-235
pubmed: 27929004
Hippocampus. 2004;14(7):919-30
pubmed: 15382260
Alzheimers Dement (N Y). 2020 Jul 16;6(1):e12050
pubmed: 32695874
Brain Stimul. 2015 Mar-Apr;8(2):260-8
pubmed: 25499037
Brain Stimul. 2020 Mar - Apr;13(2):386-392
pubmed: 31787557
Expert Rev Neurother. 2015 Feb;15(2):145-67
pubmed: 25547149
Brain Stimul. 2020 Nov - Dec;13(6):1796-1799
pubmed: 33045404
Science. 2021 Apr 2;372(6537):
pubmed: 33795429
J Psychiatr Res. 2021 Sep;141:248-256
pubmed: 34256276
Psychophysiology. 2000 Mar;37(2):163-78
pubmed: 10731767
Int J Psychophysiol. 2016 May;103:88-102
pubmed: 25660305
Arch Neurol. 2001 Feb;58(2):225-30
pubmed: 11176960
Neurobiol Aging. 2005 Feb;26(2):165-71
pubmed: 15582746
Front Hum Neurosci. 2016 Dec 27;10:668
pubmed: 28082887
J Physiol. 2000 Mar 1;523 Pt 2:503-13
pubmed: 10699092
J Neurosci. 2016 May 11;36(19):5328-37
pubmed: 27170129
Front Aging Neurosci. 2018 Jan 24;10:6
pubmed: 29416508
eNeuro. 2019 Oct 16;6(5):
pubmed: 31591137
Brain. 2018 Jul 1;141(7):1917-1933
pubmed: 29850777
Neuropsychologia. 2011 Jul;49(9):2776-83
pubmed: 21689670
Aging Clin Exp Res. 2012 Jun;24(3):218-26
pubmed: 21691143
Science. 1993 Aug 13;261(5123):921-3
pubmed: 8346443
Annu Rev Clin Psychol. 2012;8:49-76
pubmed: 22224834
Brain. 2006 Mar;129(Pt 3):564-83
pubmed: 16399806
Brain Stimul. 2021 May-Jun;14(3):531-540
pubmed: 33762220
Front Hum Neurosci. 2013 Jun 14;7:279
pubmed: 23785325
Clin Neurophysiol. 2016 Feb;127(2):1031-1048
pubmed: 26652115
Cell. 2014 May 8;157(4):845-57
pubmed: 24768692
Trends Cogn Sci. 2005 Sep;9(9):445-53
pubmed: 16054861
Front Hum Neurosci. 2013 Jun 28;7:317
pubmed: 23825454
Neuron. 2019 Jun 5;102(5):929-943.e8
pubmed: 31076275
J Alzheimers Dis. 2018;65(1):221-230
pubmed: 30010131
J Clin Neurophysiol. 2001 Mar;18(2):178-84
pubmed: 11435810
Brain Stimul. 2020 May - Jun;13(3):686-693
pubmed: 32289698
Front Neurol. 2021 May 20;12:598135
pubmed: 34093384
Clin Neurophysiol. 2020 Nov;131(11):2691-2699
pubmed: 33002731
Lancet Neurol. 2015 Sep;14(9):926-944
pubmed: 26213339
Expert Opin Drug Metab Toxicol. 2020 Aug;16(8):673-701
pubmed: 32520597
Neurobiol Learn Mem. 2021 Jul;182:107444
pubmed: 33895350
Cell. 2019 Apr 4;177(2):256-271.e22
pubmed: 30879788
Neuroimage. 2003 Dec;20(4):1934-43
pubmed: 14683699
J Man Manip Ther. 2012 Aug;20(3):160-6
pubmed: 23904756
Proc Natl Acad Sci U S A. 2000 May 23;97(11):6037-42
pubmed: 10811879
Neuropharmacology. 2010 Nov;59(6):437-43
pubmed: 20600173
NeuroRehabilitation. 2019;45(3):369-378
pubmed: 31796701
J Alzheimers Dis. 2016 Jul 1;53(4):1375-88
pubmed: 27392866
Neurobiol Aging. 2012 Jul;33(7):1481.e13-23
pubmed: 22227005
Brain Stimul. 2020 Jul - Aug;13(4):998-999
pubmed: 32330606